|
市場調査レポート
医薬品の市場再投入：製品ラインの拡大と新たな市場への参入戦略による市場シェア確保
Pharmaceutical Product Relaunch: Preserving Market Share through Line Extension and New Market Entry Strategies
|
当商品の販売は、2011年12月09日を持ちまして終了しました。
Abstract
Product teams must begin their relaunch planning early to incorporate it into
a strong overall lifecycle management strategy. As product teams enter Phase 2
of development for their initial launch, they are often planning their
relaunch strategies for years later. Early planning is one of the key factors
in making a product relaunch successful.
Cutting Edge Information analyzed the relaunch strategies outlined in this
study into two categories: Line Extensions and New Market Entries. Each line
extension or new market entry strategy profiled in this study includes a
detailed analysis of:
- Implementation costs
- Time to implement
- Strategy outcome in terms of revenue
- Market share protection gained from implementing the tactic
Product relaunch success is a combination of timing, investment and the
science behind each drug. A drug manufacturer must first identify whether a
compound may be a viable relaunch candidate. Then, the manufacturer must
determine the level of investment necessary to bring a relaunch product to
market. The next, and perhaps most important, step is for the product team to
determine when to relaunch the drug.
Cutting Edge Information' s report, Pharmaceutical Product Relaunch: Preserving
Market Share through Line Extension and New Market Entry Strategies , includes
valuable benchmarks that will help you understand the science, investments and
timing behind common relaunch strategies.
Table of Contents
- Executive Summary
- Methodology and Profiled Companies
- Pharmaceutical Product Relaunch: Five Principles for Success
- Relaunch Strategy Development
- Line Extension Relaunches
- Case Study: Brand 1
- Case Study: Brand 2
- Case Study: Brand 3
- Developing New Formulations and Delivery Systems
- Case Study: Brand 4
- New Dosing Strength and New Dosing Regimen Launches
- Case Study: Brand 5
- Marketing Pediatric Indications
- New Market Entries
- New Indication Relaunches
- Case Study: Brand 6
- Case Study: Brand 7
- Combination Therapies
- Drug Repurposing
- Case Study: Brand 8
- Case Study: Brand 9
- Relaunch Case Studies
|
